Medicilon Logo
|
search icon search icon language icon contact icon menu icon
Medicilon Logo
|
search icon close search icon language icon contact icon menu icon
CN
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
FAQs

Application of PDX Models

New drug development
In particular, patient screening and predictive biomarker study in clinical trials of tumor immune-targeted drugs. The efficacy evaluation results of PDX and clinical similarity reached 87% (CDX only 5%).

Personalized Medicine:
PDX model can be used to conduct PD evaluation experiments for tumor patients, which can be used for drug reference for clinical tumor patients.

Molecular Marker development (Biomarker)
Drug reaction -- Molecular biological mechanisms